Analysis of usefulness of serum TFF1, 2, 3 mesurement for gastric cancer screening

Not Applicable

• Conditions: gastric cancer

• Registration Number: JPRN-UMIN000001799
• Lead Sponsor: Serum TFF analyzing group

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-04-01
• Study Completion: 2012-03-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 20000

Inclusion Criteria

Not provided

Exclusion Criteria

Nothing

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Whether serum TFF1, 2, and 3 value can select people who should receive endoscopic examination for gastric cancer.

Secondary Outcome Measures

Name	Time	Method
Whether serum TFF1, 2 and 3 are better screening marker for gastric cancer than pepsinogen method.